Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 6,904,061
- Share change
- +6,904,061
- Total reported value
- $144,850,726
- Price per share
- $21.13
- Number of holders
- 34
- Value change
- +$144,850,726
- Number of buys
- 34
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2016
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q3 2016
As of 30 Sep 2016,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,904,061 shares.
The largest 10 holders included
FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Cormorant Asset Management, LLC, RA CAPITAL MANAGEMENT, LLC, BVF INC/IL, Foresite Capital Management III, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, DAFNA Capital Management LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q4 2025 Across Filers
Q4 2025 holders
310
Q3 2016 holders
34
Holder diff
-276
| Investor | Q4 2025 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.